Vaxcyte: 'Strong Buy' On VAX-31 Trial Win IPD VAX-31 And Additional Readouts 1st Half 2027
Vaxcyte: 'Strong Buy' On VAX-31 Trial Win IPD VAX-31 And Additional Readouts 1st Half 2027
Vaxcyte: 'Strong Buy' On VAX-31 Trial Win IPD VAX-31 And Additional Readouts 1st Half 2027
Personal Finance Published: Sunday, August 16, 2026, 19:50 [IST] For many EPS-95 pensioners, the monthly pension is an important part of managing regular household expenses. But one annual requirement can determine whether those payments continue smoothly: the Life Certificate, or Jeevan Pramaan Patra. Pensioners who fail to renew their certificate within its validity period could…
A judge ordered Mayor Zohran Mamdani’s controversial pied-à-terre surcharge back to square one on Tuesday, finding that the initial rollout must be redone to reach a narrower group of eligible homeowners. The suit, spearheaded by former Deputy Mayor Randy Mastro, was brought on behalf of homeowners who believed they shouldn’t have been named on any…
Movie mogul Tyler Perry has revealed that he plans to move to Puerto Rico at the beginning of 2027—as he prepares to “slow down” his famously demanding work schedule. Perry opened up about his future while appearing on “Today with Jenna & Sheinelle,” revealing that he and his 11-year-old son, Aman, will soon be trading…
National Pension System (NPS) investors reviewing performance on NPS Divas will find that returns have been weak over the past year. Category E (equity) schemes delivered an average return of –4.53 per cent, category C (corporate bonds) 4.60 per cent, and category G (government bonds) 2.60 per cent. Investors should assess whether this weakness calls…
Diageo-Moet Hennessy Alliance: Returns Shrink and Tensions Rise for New CEO By Emma Rumney Challenges and Complexities in the Diageo-Moet Hennessy Partnership LONDON, Aug 3 (Reuters) – Diageo’s decades-old partnership with Moet Hennessy has delivered shrinking returns and at times caused friction, adding to challenges facing new CEO Dave Lewis as he works to revive…
(RTTNews) – Sight Sciences, Inc. (SGHT), an eyecare technology company, on Wednesday said the U.S. Food and Drug Administration has expanded the indications for its TearCare System, making it the first treatment for meibomian gland dysfunction or MGD specifically cleared to improve gland function in patients with evaporative dry eye disease. The updated label, effective…